Kyverna TherapeuticsKYTX
那斯達克 · USD
8.52
+0.09
(+1.07%)
盤中 06/24 11:54 (UTC+8)
06/24 11:54 (UTC+8)
Kyverna TherapeuticsKYTX
8.52
+0.09
(+1.07%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 41,367 | 39,282 | 38,727 | 44,410 | 47,408 | 41,041 | 38,770 | 33,435 | 29,358 | 21,377 |
研發費用 | 30,073 | 30,014 | 30,457 | 35,816 | 37,433 | 33,483 | 29,193 | 27,321 | 22,476 | 17,163 |
推銷及管理費用 | 11,294 | 9,268 | 8,270 | 8,594 | 9,975 | 7,558 | 9,577 | 6,114 | 6,882 | 4,214 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -41,367 | -39,282 | -38,727 | -44,410 | -47,408 | -41,041 | -38,770 | -33,435 | -29,358 | -21,377 |
其他收入及費用 | 2,306 | 1,922 | 1,947 | 2,342 | 2,798 | 3,579 | 4,310 | 4,671 | 2,709 | 757 |
利息費用 | 667 | 444 | 7 | 13 | 25 | 27 | 32 | 39 | 44 | 47 |
稅前純益 | -39,728 | -37,804 | -36,787 | -42,081 | -44,635 | -37,489 | -34,492 | -28,803 | -26,693 | -20,667 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -39,728 | -37,804 | -36,787 | -42,081 | -44,635 | -37,489 | -34,492 | -28,803 | -26,693 | -20,667 |
基本每股稅後盈餘(元) | -0.66 | -0.80 | -0.85 | -0.97 | -1.03 | -0.74 | -0.80 | -0.67 | -1.12 | - |
稀釋每股稅後盈餘(元) | -0.66 | -0.79 | -0.85 | -0.97 | -1.03 | -0.88 | -0.79 | -0.54 | -1.12 | -26.86 |
基本平均股數(千股) | 60434.00 | 47155.00 | 43415.00 | 43225.00 | 43215.00 | 43304.00 | 43155.00 | 43125.00 | 23754.00 | - |
稀釋平均股數(千股) | 60434.00 | 47155.00 | 43415.00 | 43225.00 | 43215.00 | 43304.00 | 43155.00 | 43125.00 | 23754.00 | - |
還原基本每股稅後盈餘(元) | -0.66 | -0.80 | -0.85 | -0.97 | -1.03 | -0.74 | -0.80 | -0.67 | -1.12 | - |
還原稀釋每股稅後盈餘(元) | -0.66 | -0.79 | -0.85 | -0.97 | -1.03 | -0.88 | -0.79 | -0.54 | -1.12 | -26.86 |
還原基本平均股數(千股) | 60,434 | 47,155 | 43,415 | 43,225 | 43,215 | 43,304 | 43,155 | 43,125 | 23,754 | - |
還原稀釋平均股數(千股) | 60,434 | 47,155 | 43,415 | 43,225 | 43,215 | 43,304 | 43,155 | 43,125 | 23,754 | - |
EBITDA(千元) | -39,440 | -38,360 | -37,932 | -43,396 | -46,219 | -39,135 | -36,795 | -30,489 | -26,447 | -20,763 |